Your email has been successfully added to our mailing list.

×
-0.00105181964799106 -0.000140242619732208 -0.000210363929598213 0.000560970478928435 0.00767828343033447 0.00722249491620504 0.00224388191571414 0.00385667204263364
Stock impact report

Alnylam falls 9% after Q1 earnings miss, cut in 2022 net product revenues guidance [Seeking Alpha]

Alnylam Pharmaceuticals, Inc. (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
Company Research Source: Seeking Alpha
Alnylam falls 9% after Q1 earnings miss, cut in 2022 net product revenues guidanceApr. 28, 2022 1:20 PM ETAlnylam Pharmaceuticals, Inc. ()By: Anuron MitraSA News Editorsankai/iStock via Getty ImagesDue to its operating loss in Q1, 's cash and cash equivalents fell to $2.24B as of March 31 vs. $2.44B as of Dec. 31.Earlier in Q1, Up to Wednesday's close, stock -8.6% YTD. Show less Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ALNY alerts
Opt-in for
ALNY alerts

from News Quantified
Opt-in for
ALNY alerts

from News Quantified